Pfizer Asia Manufacturing Pte Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Singapore
- Registered address
- 11 Tuas Bay Street, Singapore, 639164, Singapore (SGP)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3003901862 · DUNS 936889401
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-10-18
- VAIDrug Quality Assurance2021-10-27
- VAIDrug Quality Assurance2017-03-24
- NAIDrug Quality Assurance2015-12-03
- NAIDrug Quality Assurance2013-03-01
- NAIDrug Quality Assurance2009-03-19
Drugs this plant is listed as making
9 distinct drugs across 39 products name this site in their FDA label.
- Amlodipine and AtorvastatinPrasco Laboratories
- CrizotinibPfizer Laboratories Div Pfizer Inc
- desvenlafaxine succinateWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- ExemestaneMylan Pharmaceuticals Inc.
- linezolidPharmacia & Upjohn Company LLC
- Sunitinib malatePfizer Laboratories Div Pfizer Inc
- tafamidisPfizer Laboratories Div Pfizer Inc
- tofacitinibPfizer Laboratories Div Pfizer Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.